with nearly all subjects developing hepatitis A antibodies (anti-HAV) within 2 weeks. [3] However, a second dose of vaccine, given 6 or 12 to 18 months after the first dose in accordance with the ...

Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.

Some people may remain ill after COVID infection because the virus still lurks in their bodies. The looming question now is: ...

The Kaiser Permanente Hawaii Viral Hepatitis Clinic reached a milestone by curing its 1,000th patient of hepatitis C. “It’s a very satisfying thing to make that call and tell someone they’re cured,” ...

Here we go again. From the New York Health Department: Anyone Who Ate Food From ilili Restaurant During January 31 – February ...

Hawaii’s Kaiser Permanente Viral Hepatitis Clinic has reached a major milestone toward combative Hepatitis outcomes. On ...

10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior ...

An estimated 2 million adults in the US have chronic hepatitis C, with new infections on the rise. Many patients are unaware ...

Bipartisan efforts to amend a bill that will allow parents and guardians religious and conscientious objections to West ...

Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...